New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

The American Civil Liberties Union also filed a lawsuit last week, alleging that the federal agency and its parent department ...

As influencers tout methylene blue as a cognitive enhancer and anti-aging solution, experts caution about its serious risks ...

SINKING SPRING, Pa. – An art contest featuring a Pennsylvania-made treat is raising money for the Alzheimer's Association. Participants got their creative juices flowing using Peeps at "The Residence ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...

As the Trump administration makes major cuts to federal health agencies, including the National Institutes of Health, some Alzheimer’s experts are worried about research for the brain-impairing ...

On 5 April 2025 at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases, held in Vienna, Austria, ...